Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $421.93 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt LLC | $116.17 | 1 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $115.37 | 7 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $92.53 | 1 | $0 (2017) |
| AMAG Pharmaceuticals, Inc. | $86.63 | 1 | $0 (2021) |
| Organon LLC | $11.23 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $11.23 | 1 | Organon LLC ($11.23) |
| 2021 | $86.63 | 1 | AMAG Pharmaceuticals, Inc. ($86.63) |
| 2019 | $99.35 | 6 | Avanir Pharmaceuticals, Inc. ($99.35) |
| 2018 | $132.19 | 2 | Mallinckrodt LLC ($116.17) |
| 2017 | $92.53 | 1 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($92.53) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/19/2023 | Organon LLC | — | Food and Beverage | In-kind items and services | $11.23 | General |
| 08/11/2021 | AMAG Pharmaceuticals, Inc. | FERAHEME (Drug) | Food and Beverage | In-kind items and services | $86.63 | General |
| Category: For the treatment of iron deficiency anemia associated with chronic kidney disease | ||||||
| 11/05/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $10.79 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 04/19/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 03/17/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/27/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.44 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 02/16/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/14/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 12/05/2018 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 05/03/2018 | Mallinckrodt LLC | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $116.17 | General |
| Category: AUTOIMMUNE AND RARE DISEASE | ||||||
| 12/05/2017 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $92.53 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 961 | 1,310 | $302,146 | $118,375 |
| 2022 | 12 | 778 | 1,184 | $239,081 | $93,706 |
| 2021 | 10 | 567 | 903 | $190,433 | $73,486 |
| 2020 | 10 | 599 | 1,018 | $217,038 | $85,969 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 239 | 244 | $92,720 | $32,926 | 35.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 207 | 443 | $73,074 | $29,363 | 40.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 118 | 215 | $52,245 | $21,536 | 41.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 175 | 181 | $32,218 | $17,252 | 53.5% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 165 | 170 | $30,770 | $10,473 | 34.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 20 | 20 | $11,840 | $3,501 | 29.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $7,416 | $2,446 | 33.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 13 | 13 | $1,863 | $877.76 | 47.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 152 | 373 | $74,079 | $29,784 | 40.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 170 | 338 | $48,854 | $19,140 | 39.2% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2022 | 156 | 163 | $28,810 | $10,198 | 35.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 59 | 59 | $22,132 | $9,457 | 42.7% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 106 | 107 | $19,636 | $8,942 | 45.5% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 34 | 34 | $14,160 | $4,870 | 34.4% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 29 | 30 | $9,300 | $3,858 | 41.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 19 | 23 | $11,496 | $3,839 | 33.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 11 | 12 | $3,720 | $1,097 | 29.5% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 15 | 18 | $3,090 | $1,024 | 33.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 16 | 16 | $2,291 | $856.21 | 37.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 11 | 11 | $1,513 | $640.81 | 42.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 141 | 375 | $68,625 | $29,733 | 43.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 54 | 139 | $17,653 | $7,645 | 43.3% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 123 | 126 | $21,420 | $7,416 | 34.6% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 49 | 51 | $26,010 | $6,602 | 25.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 30 | 39 | $18,954 | $6,437 | 34.0% |
About Dr. Niket Shah, D.O
Dr. Niket Shah, D.O is a Internal Medicine healthcare provider based in Parkersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1376985630.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Niket Shah, D.O has received a total of $421.93 in payments from pharmaceutical and medical device companies, with $11.23 received in 2023. These payments were reported across 11 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($421.93).
As a Medicare-enrolled provider, Shah has provided services to 2,905 Medicare beneficiaries, totaling 4,415 services with total Medicare billing of $371,536. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Parkersburg, WV
- Active Since 07/26/2013
- Last Updated 10/03/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1376985630
Products in Payments
- ACTHAR (Biological) $116.17
- NUEDEXTA (Drug) $115.37
- LifeVest (Device) $92.53
- FERAHEME (Drug) $86.63
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Parkersburg
Jennifer Leavitt, D.o, D.O
Internal Medicine — Payments: $9,943
Orton Armstrong, M.d, M.D
Internal Medicine — Payments: $9,663
William Tomlinson, Md, MD
Internal Medicine — Payments: $8,023
Bairava Kuppuswamy, M.d, M.D
Internal Medicine — Payments: $6,502
Michael Cheshire, D.o, D.O
Internal Medicine — Payments: $5,388
Abiy Kelil, M.d, M.D
Internal Medicine — Payments: $3,922